Navigation Links
Enzyme Critical for Early Growth of Abdominal Aortic Aneurysms

Surgery is the only treatment for an abdominal aortic aneurysm, a weak spot in the body's main artery that dilates dangerously// over time. If the vessel ruptures suddenly before surgery to repair it, a quick death is virtually certain. Now, scientists say they have identified a key enzyme that triggers chronic inflammation in the aorta and promotes the growth of aneurysms. Their finding raises hopes for developing a drug that could prevent small aneurysms from enlarging to the point where surgery is necessary.

Genetically engineered mice that lack the enzyme dipeptidyl peptidase I (DPPI) do not develop aortic aneurysms, researchers at Washington University School of Medicine in St. Louis report in the online edition of the Proceedings of the National Academy of Sciences U.S.A. 'We think DPPI is a viable therapeutic target that may keep the growth of aortic aneurysms in check, so they don't become life threatening,' says Robert W. Thompson, M.D., professor of surgery and one of the senior investigators on the article.

The new research shows that DPPI is critical for the recruitment of inflammatory cells to the aortic wall, and that these cells push the inflammation from an acute phase into a chronic phase. The researchers suspect that this chronic inflammation eventually causes other enzymes to eat away at the structural proteins of the aorta, causing the vessel to balloon slowly and ultimately rupture in patients whose aortas are greatly distended.

Abdominal aortic aneurysms kill about 15,000 Americans each year and have claimed the lives of such notables as Albert Einstein and Lucille Ball. The condition often goes undiagnosed because small aneurysms rarely cause symptoms. Typically, they are discovered by accident when patients have an X-ray or ultrasound for another medical concern.

If an aneurysm is small, doctors generally monitor it closely and recommend surgery only if its diameter grows larger than 5.5 centime
'"/>




Page: 1 2 3

Related medicine news :

1. Enzyme may be target for obesity drugs
2. Researchers trick Alzheimers Enzyme
3. Enzyme stimulates growth of adult stem cells
4. Enzyme may aid hold back disease
5. Enzyme help destroy cancer cell
6. Enzyme Associated with Memory
7. Enzyme Associated With Memory
8. Brain Enzyme Found To Regulate Weight
9. New Enzyme Identified For Arthritis
10. Enzyme for treatment of arthritis
11. An Enzyme That Turns a One –time Experience into a long-time Memor
Post Your Comments:
(Date:12/6/2009)... Blood clotting, or coagulation, is an important process ... is injured. Sometimes, however, clots form on the ... do not dissolve naturally, a potentially life-threatening situation ... Annual Meeting of the American Society of Hematology ... aspirin and heparin with the hope of preventing ...
(Date:12/6/2009)... says dangerous substances such as asbestos have been found in toys ... ... (PRWEB) December 6, 2009 -- As parents shop for children,s toys ... recalls due to lead paint or asbestos contamination, says a New ... emergency rooms each year due to toy-related injuries,” says Joseph W. ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor ... the knot, since research has shown that never-married adults have ... something wrong with those who go it alone anyway? , ... measures shows that never-married people aged 40 and up can ...
(Date:12/5/2009)... up in the most unusual places, and to do everything from growing ... ... 5, 2009 -- Who would have thought that your wine, water and ... Texas has announced a new line of turbines, for industry end users, ...
Breaking Medicine News(10 mins):Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3
... is better than using one to stage lung cancer, and ... surgical method now most commonly used, researchers at Mayo Clinic ... the Journal of the American Medical Association. , This new ... is inserted into a patients esophagus to access lymph nodes ...
... ATRC ), a medical device company and a ... results for the fourth,quarter and full year ended December ... host a conference call at 10:00 a.m. ET on ... year 2007 results. A,live web cast of the conference ...
... Dr. Azimi offers total dental makeover to downtown Las Vegan, ... Americans, you,think extreme smile makeovers are for celebrities and the ... Las Vegas, downtown,general and cosmetic dentist, has reserved the dental ... For the first time, Dr. Azimi has agreed to donate ...
... adverse events for heart patients is in early period , , ... the first three months after heart patients stop taking the ... the first study to make this observation," said Dr. P. ... and lead author of a report in the Feb. 6 ...
... The MayaTech Corporation, a,leading provider of ... expanded its services with the establishment of ... center will study the,legal, regulatory, ethical, and ... "MayaTech recognizes that nanotechnology offers exciting,possibilities," says ...
... There is a lack of equity in health care ... in a nationwide survey and analyzed by a UT ... available online and published as an abstract in the ... certain disparities are particularly pronounced for specific racial and ...
Other Medicine News:Health News:Researchers find less invasive, highly accurate methods 2Health News:Researchers find less invasive, highly accurate methods 3Health News:Researchers find less invasive, highly accurate methods 4Health News:AtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2007 Financial Results 2Health News:A Downtown Las Vegas Dental Makeover by Dr. Azimi for the Most Deserving Resident or Working Professional 2Health News:First 90 Days After Stopping Plavix Most Dangerous 2Health News:MayaTech Establishes Center to Focus on Breakthrough Technology 2Health News:National survey shows minority children experience multiple disparities in health care 2
(Date:12/4/2009)... BETHESDA, Md., Dec. 4 Drs. Neal Shore and ... recurrence from the additional analysis of secondary end points ... study of FIRMAGON® (monthly degarelix for injection) or monthly ... of treatment. Prostate cancer patients who received FIRMAGON ...
(Date:12/3/2009)... 3 Guidepoint Global, LLC , a leading primary ... Tracker, a monthly longitudinal data release that monitors and projects ... ,, The Sleep Apnea Tracker captures actual patient usage ... United States from 15 different equipment providers going back to ...
(Date:12/3/2009)... (Nasdaq: PCYC ), a biopharmaceutical company focused on ... treatment of immune mediated diseases and cancer, today announced ... on, Tuesday, December 8, 2009 at 11:00am Eastern Time ... clinical data regarding its HDAC Program (PCI-24781) and its ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 1CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 2CareFusion Launches 10 Pound High Performance Critical Care Ventilator in the U S 10347 3Many Hospitalized With Swine Flu Had Been Healthy 59397 1Many Hospitalized With Swine Flu Had Been Healthy 59397 2Many Hospitalized With Swine Flu Had Been Healthy 59397 3Scientists urge EPA to adopt systems thinking 10344 1
... Alnylam,Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi ... for Cancer,Research (AACR) 2007 Annual Meeting that ... ALN-VSP01, for the,treatment of liver cancer and ... program. ALN-VSP01 is an RNAi therapeutic that ...
... in Largest-Ever IVF Trial,in US, RANCHO MIRAGE, ... of,four studies evaluating Ferring Pharmaceuticals' ENDOMETRIN(R), a,novel ... phase,support (supplementation to provide support for implantation ... reproductive,technologies (ART) were presented at the 55th ...
Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5